Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-034436

Chairman and CEO bought 4,504 shares at an average $1.46 ($6,591)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2021-05-18 Purchase +504 $1.57 $791 10,728,050 D
Niihara Yutaka Chairman and CEO 2021-05-19 Purchase +4,000 $1.45 $5,800 10,732,050 D
Open-market purchases · 4,504 sh · avg $1.46 · $6,591
Loading xslF345X03/doc4.xml…